Published in J Med Virol on February 01, 2006
HIV-1 viral load assays for resource-limited settings. PLoS Med (2006) 3.30
Current practices in laboratory monitoring of HIV infection. Indian J Med Res (2011) 0.94
Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients. J Acquir Immune Defic Syndr (2009) 0.92
HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays. J Clin Virol (2009) 0.85
Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe. Biomed Res Int (2014) 0.81
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings? BMJ Open (2016) 0.75
Assessment of the Cavidi ExaVir™ Load assay for monitoring plasma viral load in HIV-2 infected patients. J Clin Microbiol (2017) 0.75
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol (2002) 2.83
Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine (2008) 2.37
Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine (2005) 1.69
Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. Antivir Ther (2008) 1.62
Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr (2002) 1.59
Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population. Am J Nephrol (2011) 1.52
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS (2003) 1.45
Are intestinal helminths risk factors for developing active tuberculosis? Trop Med Int Health (2006) 1.42
The HIV/AIDS pandemic: at last good news. Scand J Public Health (2004) 1.39
IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses (2005) 1.39
HIV prevalence in 72 000 urban and rural male army recruits, Ethiopia. AIDS (2003) 1.35
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis (2008) 1.34
Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol (2007) 1.30
Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS (2003) 1.29
Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics. Scand J Infect Dis (2002) 1.27
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J Clin Microbiol (2005) 1.27
Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther (2007) 1.27
HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol (2003) 1.25
Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol (2005) 1.24
African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med (2008) 1.23
Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia. Clin Vaccine Immunol (2006) 1.22
Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol (2003) 1.18
Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Ethiop Med J (2002) 1.16
Evaluation of Determine HIV-1/2 rapid diagnostic test by 4th generation ELISA using blood donors' serum at Felege Hiwot Referral Hospital, northwest Ethiopia. Ethiop Med J (2008) 1.10
Evidence of changes in sexual behaviours among male factory workers in Ethiopia. AIDS (2003) 1.09
Intestinal microsporidiosis in diarrheal patients infected with human immunodeficiency virus-1 in Addis Ababa, Ethiopia. Jpn J Infect Dis (2006) 1.02
Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia. Scand J Infect Dis (2003) 1.00
The impact of asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in north-west Ethiopia. PLoS One (2012) 0.99
Prevalence and incidence of, and risk factors for, HIV-1 infection among factory workers in Ethiopia, 1997-2001. J Health Popul Nutr (2005) 0.97
Population genetics of chronic kidney disease: the evolving story of APOL1. J Nephrol (2012) 0.96
Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr (2002) 0.92
Indeterminate human immunodeficiency virus Western blot profiles in ethiopians with discordant screening-assay results. Clin Diagn Lab Immunol (2002) 0.91
Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers. J Infect Dis (2005) 0.90
Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia. Clin Vaccine Immunol (2006) 0.90
Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration. PLoS Negl Trop Dis (2010) 0.89
Evaluation of rapid HIV test kits on whole blood and development of rapid testing algorithm for voluntary testing and counseling centers in Ethiopia. Ethiop Med J (2004) 0.88
Herpes simplex virus type 2 seropositivity among urban adults in Africa: results from two cross-sectional surveys in Addis Ababa, Ethiopia. Sex Transm Dis (2002) 0.88
Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing. AIDS (2003) 0.88
Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia. Ethiop Med J (2010) 0.87
Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia. J Clin Microbiol (2004) 0.87
Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis. Clin Vaccine Immunol (2012) 0.87
Knowledge and attitudes towards antiretroviral therapy among factory workers participating in a cohort on HIV and AIDS, Addis Ababa, Ethiopia. Ethiop Med J (2003) 0.86
Evaluation of blood collection filter papers for HIV-1 DNA PCR. J Clin Virol (2012) 0.86
Transmission of herpes simplex virus Type 2 among factory workers in Ethiopia. J Infect Dis (2004) 0.86
Timing of blood sampling for CD4 T-cell counting influences HAART decisions. Ethiop Med J (2011) 0.86
Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection. BMC Infect Dis (2008) 0.85
Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease. Scand J Infect Dis (2010) 0.85
Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. J Leukoc Biol (2006) 0.85
Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity. PLoS One (2010) 0.85
Differences in HIV type 1 RNA plasma load profile of closely related cocirculating Ethiopian subtype C strains: C and C'. AIDS Res Hum Retroviruses (2010) 0.83
Early treatment response evaluated by a clinical scoring system correlates with the prognosis of pulmonary tuberculosis patients in Ethiopia: a prospective follow-up study. Scand J Infect Dis (2012) 0.83
Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin. J Infect Dis (2002) 0.82
Detection of intestinal microsporidiosis in diarrhoeal patients infected with the human immunideficiency virus (HIV-1) using PCR and Uvitex-2B stain. Ethiop Med J (2005) 0.82
Surveillance technology for HIV-1 subtype C in Ethiopia: an env-based NASBA molecular beacon assay to discriminate between subcluster C and C'. J Virol Methods (2005) 0.81
Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden. Scand J Infect Dis (2012) 0.80
HIV prevalence in 72,000 urban and rural male army recruits, Ethiopia, 1999-2000. Ethiop Med J (2003) 0.80
Evidence of genetic variability of human immunodeficiency virus type 1 in plasma and cervicovaginal lavage in ethiopian women seeking care for sexually transmitted infections. AIDS Res Hum Retroviruses (2005) 0.80
Alternative approach to blood screening using the ExaVir reverse transcriptase activity assay. Curr HIV Res (2005) 0.79
Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis. Trans R Soc Trop Med Hyg (2005) 0.79
[Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study]. Lakartidningen (2012) 0.79
Evaluation of rapid assays for screening and confirming HIV-1 infection in Ethiopia. Ethiop Med J (2002) 0.78
Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians. AIDS (2007) 0.78
HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians. J Acquir Immune Defic Syndr (2007) 0.78
Overall HIV-1 prevalence in pregnant women over-estimates HIV-1 in the predominantly rural population of Afar Region. Ethiop Med J (2003) 0.78
HIV-1 seroprevalence and subtypes in police recruits from Afar regional state, Ethiopia. Ethiop Med J (2002) 0.78
Application of a colorimetric chain-termination assay for characterization of reverse transcriptase from 3'-azido-2',3'-deoxythymidine-resistant HIV isolates. Biotechnol Appl Biochem (2002) 0.78
Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. Ethiop Med J (2003) 0.78
Assessment of the implementation of HIV-rapid test kits at different levels of health institutions in Ethiopia. Ethiop Med J (2007) 0.76
Possible transmission of zoonoses in xenotransplantation: porcine endogenous retroviruses (PERVs) from an immunological point of view. Acta Vet Scand Suppl (2004) 0.76
Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients. Ethiop Med J (2011) 0.75
Low-cost liquid medium for in vitro cultivation of Leishmania parasites in low-income countries. Glob Health Action (2009) 0.75
[Painfully single-minded about fibromyalgia]. Lakartidningen (2008) 0.75
[In Process Citation]. Lakartidningen (2015) 0.75
Co-infection of Onchocerca volvulus and intestinal helminths in indigenous and migrant farmers in southwest Ethiopia. Ethiop Med J (2002) 0.75
Cholera and car accidents. Lancet (2006) 0.75
Evidence of changes in sexual behaviours among male factory workers in Ethiopia. Ethiop Med J (2003) 0.75
Development of research capability in Ethiopia: the Ethio-Netherlands AIDS research project (ENARP): 1994-2002, achievements, scientific findings and project goals. Ethiop Med J (2003) 0.75
[Babel's House revisited...]. Lakartidningen (2008) 0.75
[Screening for HIV and hepatitis C virus using saliva tests in a prison in Ghana. A study of the prevalence and the status of knowledge]. Lakartidningen (2012) 0.75
[Art and psychiatry]. Lakartidningen (2009) 0.75
[Burnout in Greene-land]. Lakartidningen (2007) 0.75